文献速递头颈外科

人乳头瘤病毒相关口咽鳞状细胞癌经口机器人手术后营养结局

Nutritional Outcomes in HPV-Associated Oropharyngeal Squamous Cell Carcinoma After Transoral Robotic Surgery.
PubMed 文献 · Laryngoscope · 2025-05-13

本研究纳入2016年1月至2023年12月因HPV相关口咽鳞状细胞癌接受经口机器人手术的160例患者,评估术后吞咽与体重变化。结果显示辅助放化疗与术后3个月至3年体重下降显著相关,但吞咽结局无显著差异;术后鼻胃管依赖时间延长与后续喂养管替换率升高显著相关。

要点

  • TORS术后接受辅助放疗或放化疗者3个月至3年体重下降显著大于单纯手术者。
  • 辅助放疗与放化疗两组间体重下降无显著差异,吞咽结局亦无显著差异。
  • 术后鼻胃管依赖时间延长与后期喂养管替换率升高显著相关。

核心结论

  • TORS术后辅助治疗与显著更大的长期体重下降相关,但未显著改变吞咽结局。
  • 术后鼻胃管依赖时间较长与治疗后期肠内喂养依赖率较高相关。

研究设计与样本

  • 回顾性纳入2016年1月至2023年12月因HPV相关口咽鳞状细胞癌接受TORS的全部患者,共160例。
  • 从电子病历收集体重下降、功能性经口摄入、喂养管依赖、人口学特征及治疗过程。

主要发现

  • 160例中男性占87.5%,中位年龄60.0岁;pT1占53.8%、pT2占40.0%,pN1占78.1%。
  • 31.9%仅接受TORS,42.5%接受辅助放疗,25.6%接受辅助放化疗;中位随访2.27年(范围0.26-7.56年)。
  • 87.4%患者在TORS期间放置鼻胃管。
  • 术后鼻胃管依赖时间延长与后期喂养管替换率升高显著相关(p < 0.001;95% CI,1.051-1.181)。
  • 术后3个月至3年体重下降在接受辅助放疗和放化疗的患者中显著更大(p < 0.001),尽管吞咽结局无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Nutritional outcomes following transoral robotic surgery (TORS) for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma (OPSCC) are poorly understood. This study evaluates how TORS, with or without adjuvant treatment, impacts swallowing and weight loss. METHODS: All patients treated with TORS for HPV-associated OPSCC from January 2016 to December 2023 were included. Weight loss, functional oral intake, feeding tube dependence, patient demographics, and treatment course were collected from patients' electronic medical records. RESULTS: In total, 160 patients with HPV-associated OSPCC treated with TORS were included. 87.5% were male, with a median age of 60.0 years. Most patients were diagnosed with pT1 (53.8%) or pT2 (40.0%) and pN1 (78.1%) disease. 31.9% underwent TORS alone, while 42.5% received adjuvant radiation and 25.6% adjuvant chemoradiation. The median follow-up time was 2.27 (range 0.26-7.56) years. 87.4% of patients underwent nasogastric tube placement during TORS. Prolonged postoperative nasogastric tube dependence was significantly associated with increased rates of feeding tube replacement (p < 0.001; 95% CI, 1.051-1.181) later during treatment. Weight loss from three months to three years postoperatively was significantly greater in patients who received adjuvant radiation and chemoradiation (p < 0.001), despite no significant difference in swallowing outcomes. There was no significant difference in weight loss between adjuvant radiation and chemoradiation groups. CONCLUSIONS: Adjuvant treatment following TORS is associated with significantly greater long-term weight loss but does not significantly alter swallowing outcomes. Longer duration of nasogastric tube dependence in the postoperative period is associated with higher rates of enteral feeding dependence later in treatment.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Bzhilyanskaya V, Tong JY, Ferris MJ, et al. Nutritional Outcomes in HPV-Associated Oropharyngeal Squamous Cell Carcinoma After Transoral Robotic Surgery. Laryngoscope. 2025. PMID: 40359314. doi:10.1002/lary.32264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。